Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

BACKGROUND: Antivascular endothelial growth factor tyrosine kinase inhibitors have been used recently in the treatment of advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC). Off-label sorafenib is used in Turkey with special permission by the Ministry of Health for this...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Onco Targets Ther
Egile Nagusiak: Benekli, Mustafa, Yalcin, Suayib, Ozkan, Metin, Elkiran, Emin Tamer, Sevinc, Alper, Cabuk, Devrim, Coskun, Hasan Senol, Oksuzoglu, Berna, Bayar, Banu, Akbulat, Akif, Ozet, Ahmet
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2014
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4271783/
https://ncbi.nlm.nih.gov/pubmed/25548522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S70670
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak